CN118510492A - 包含沙丁胺醇的药物组合物 - Google Patents

包含沙丁胺醇的药物组合物 Download PDF

Info

Publication number
CN118510492A
CN118510492A CN202280081939.8A CN202280081939A CN118510492A CN 118510492 A CN118510492 A CN 118510492A CN 202280081939 A CN202280081939 A CN 202280081939A CN 118510492 A CN118510492 A CN 118510492A
Authority
CN
China
Prior art keywords
pharmaceutical composition
mass
salbutamol
active ingredient
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280081939.8A
Other languages
English (en)
Chinese (zh)
Inventor
伊莎贝尔·佩龙
艾琳·罗西
塞格琳·萨拉伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aptar France SAS
Original Assignee
Aptar France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aptar France SAS filed Critical Aptar France SAS
Publication of CN118510492A publication Critical patent/CN118510492A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CN202280081939.8A 2021-12-20 2022-12-19 包含沙丁胺醇的药物组合物 Pending CN118510492A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FRFR2113999 2021-12-20
FR2113999A FR3130554B1 (fr) 2021-12-20 2021-12-20 Composition pharmaceutique comprenant du salbutamol
PCT/FR2022/052421 WO2023118717A1 (fr) 2021-12-20 2022-12-19 Composition pharmaceutique comprenant du salbutamol

Publications (1)

Publication Number Publication Date
CN118510492A true CN118510492A (zh) 2024-08-16

Family

ID=80595325

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280081939.8A Pending CN118510492A (zh) 2021-12-20 2022-12-19 包含沙丁胺醇的药物组合物

Country Status (9)

Country Link
US (1) US20250041244A1 (https=)
EP (1) EP4452227B1 (https=)
JP (1) JP2024546201A (https=)
CN (1) CN118510492A (https=)
AU (1) AU2022420913A1 (https=)
CA (1) CA3238932A1 (https=)
FR (1) FR3130554B1 (https=)
MX (1) MX2024006942A (https=)
WO (1) WO2023118717A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20250281404A1 (en) * 2024-03-07 2025-09-11 Recipharm Laboratories, Inc. Composition for use in pressurised dispensing container

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007020204A2 (en) * 2005-08-12 2007-02-22 Boehringer Ingelheim Pharma Gmbh & Co. Kg Hfc solution formulations for inhalation containing salbutamol hydrochloride or salbutamol citrate
GB201117621D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
GB201117619D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
GB201306984D0 (en) 2013-04-17 2013-05-29 Mexichem Amanco Holding Sa Composition
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition

Also Published As

Publication number Publication date
CA3238932A1 (fr) 2023-06-29
EP4452227C0 (fr) 2025-11-26
MX2024006942A (es) 2024-09-10
EP4452227B1 (fr) 2025-11-26
JP2024546201A (ja) 2024-12-18
US20250041244A1 (en) 2025-02-06
AU2022420913A1 (en) 2024-05-23
FR3130554B1 (fr) 2024-10-18
FR3130554A1 (fr) 2023-06-23
EP4452227A1 (fr) 2024-10-30
WO2023118717A1 (fr) 2023-06-29

Similar Documents

Publication Publication Date Title
JP4659160B2 (ja) 噴射剤フリーエアゾール製造用新規水性医薬製剤
WO2004019985A1 (en) Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
HUP0001339A2 (hu) Aeroszol gyógyszerkészítmény
WO2007144604A1 (en) Stable aerosol pharmaceutical formulations
JP2016519160A (ja) ３つ以上の活性薬剤を呼吸性送達するための組成物、方法、及びシステム
JP3264496B2 (ja) クロロフルオロカーボンを含まないモメタゾンフロエートエーロゾルの処方物
JP7828949B2 (ja) 吸入投与のための併用療法
EP1280532A1 (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
JP5938476B2 (ja) 呼吸器疾患を治療するための定量噴霧式吸入剤を調製する方法
CN118510492A (zh) 包含沙丁胺醇的药物组合物
TWI449523B (zh) 福莫特羅（ｆｏｒｍｏｔｅｒｏｌ）及二丙酸倍氯米松（ｂｅｃｌｏｍｅｔａｓｏｎｅ ｄｉｐｒｏｐｉｏｎａｔｅ）之醫藥噴霧劑配方
US20130104881A1 (en) Stabilized Metered Dose Inhaler
JP2005536538A (ja) 薬学的組成物
US20260000630A1 (en) Pharmaceutical composition comprising salbutamol
US12383516B1 (en) Albuterol aerosol suspension formulation for oral inhalation with high amount of green propellant hydrofluoroolefin (HFO) and free of co-solvent
TW202525298A (zh) 一種吸入性醫藥製劑、裝置及其用途
TWI383807B (zh) 醫學氣霧配方
EP4452230A1 (en) Compositions, methods and systems for aerosol drug delivery
JP2025137301A (ja) 加圧分配容器における使用のための組成物
JP6653323B2 (ja) 吸入可能な製剤
TW202600124A (zh) 一種吸入性醫藥製劑、裝置及其用途
BR102012027127A2 (pt) Composição contida em um inalador farmacêutico pressurizado com medidores de dosagem

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination